TAVR Valve: An Evidence-Based Patient Guide

A TAVR valve is an artificial heart valve placed by catheter to treat severe aortic stenosis, a narrowing of the aortic valve that can limit blood flow from the heart. It can be an effective alternative to surgical valve replacement for appropriately selected patients, but the best approach depends on anatomy, health, age, valve durability needs and personal priorities.

Overview: what is a TAVR valve?

A TAVR valve is a replacement aortic valve used during transcatheter aortic valve replacement (TAVR). TAVR is a minimally invasive procedure that treats severe aortic stenosis, a condition in which the aortic valve becomes stiff and narrow. The replacement valve is carried to the heart through a thin tube called a catheter and expanded within the diseased valve.

The aortic valve controls blood flow from the heart’s main pumping chamber to the body. When severe narrowing develops, the heart must work harder to push blood through it. This may lead to breathlessness, chest discomfort, fatigue, dizziness or fainting. TAVR does not remove the old valve; instead, the new valve pushes the old leaflets aside and takes over valve function.

TAVR patient education should emphasize that the procedure is not automatically right for everyone. A multidisciplinary heart team, typically including interventional cardiologists, cardiac surgeons, imaging specialists, anesthesiologists and other clinicians, compares TAVR with surgical aortic valve replacement (SAVR) and supportive care when relevant.

How the TAVR procedure works

Most TAVR procedures use the transfemoral approach, meaning the catheter enters through an artery near the top of the leg. Other access routes may be considered when the leg arteries are too narrow, blocked or otherwise unsuitable. The valve itself usually consists of biological tissue mounted on a metal frame that can be expanded with a balloon or can expand on its own.

Before treatment, clinicians use echocardiography and detailed CT imaging to measure the aortic valve, examine blood vessels and select an appropriately sized device. Coronary artery assessment, blood tests, kidney function testing and a review of medications also help the team plan safely. This careful preparation is a central part of evidence-based TAVR care.

During the procedure, the team guides the catheter to the heart using continuous X-ray imaging. The replacement valve is positioned inside the narrowed valve and deployed. The team immediately checks blood flow and valve function with imaging. The procedure is commonly performed with sedation or general anesthesia, depending on individual needs and local practice.

Who may be a candidate for TAVR?

TAVR is used primarily for people with severe aortic stenosis who have symptoms or whose heart function is being affected. It may be considered across a range of surgical-risk groups, but suitability is individualized. Symptoms such as exertional breathlessness, reduced exercise tolerance, chest pain, light-headedness and fainting should prompt medical assessment, particularly in a person known to have a heart murmur or valve disease.

Age alone does not determine candidacy. The heart team considers expected lifespan, overall health, frailty, anatomy, the condition of the arteries, prior chest surgery, kidney function, coronary artery disease and the likely need for future valve procedures. The long-term durability of a valve and the practicalities of future coronary artery access are also important discussion points, especially for younger patients.

People seeking a TAVR patient information PDF, TAVR patient education PDF or TAVR patient handout should use these resources as preparation for an individual consultation rather than as a substitute for it. A clinician can explain how test results and personal goals affect the recommendation.

What disqualifies you from TAVR?

There is no single universal disqualifier for TAVR. Some people are better served by surgery because of their age, anatomy, need for another heart operation, or preference for a surgical approach. For example, surgery may be favored when a person also needs coronary bypass surgery, has disease of the ascending aorta, or has another valve problem that requires repair.

Certain anatomical features can make standard catheter access difficult or unsafe. These include very small or heavily diseased blood vessels, an aortic valve anatomy that creates an unacceptably high risk of blocking a coronary artery, or sizing that is not suitable for available valve devices. Alternative access routes may still be possible in selected cases.

Active infection, particularly infective endocarditis, generally needs treatment before valve replacement is considered. TAVR may also offer limited benefit when severe illness, advanced frailty or another condition is expected to prevent meaningful improvement in quality or length of life. These are sensitive, individualized decisions made with the patient and, when desired, family members.

Step by step: what happens before, during and after TAVR?

Before TAVR, patients usually undergo echocardiography, CT scanning, electrocardiography, blood tests and a clinical review. The care team gives instructions about eating and drinking before admission and explains which medicines should be continued, paused or adjusted. People should not stop blood thinners, diabetes medicines or other prescribed drugs without specific medical guidance.

On the day of treatment, monitors are placed to track heart rhythm, blood pressure and oxygen levels. After anesthesia or sedation is provided, the catheter is introduced through the selected blood vessel and the TAVR valve is implanted. The procedure length varies according to anatomy and whether additional treatment, such as coronary intervention, is needed.

Afterward, patients are monitored closely for bleeding at the access site, changes in heart rhythm, neurological symptoms and kidney function. Many people are encouraged to sit up and walk with assistance relatively soon after a transfemoral procedure. The medical team determines when it is safe to return home and provides a personalized medication and follow-up plan.

Benefits, evidence and the big five complications after TAVR

In appropriately selected patients with severe symptomatic aortic stenosis, TAVR can improve symptoms, daily function and survival compared with no valve replacement. Studies comparing TAVR and surgery have shown that both approaches can provide strong outcomes in selected populations. However, the findings do not mean that one procedure is best for every person; study results must be applied to the individual’s anatomy, age, health and treatment goals.

The big five complications commonly discussed after transcatheter aortic valve replacement are stroke; bleeding or injury to the blood vessel used for access; conduction disturbances that may require a permanent pacemaker; leakage around the replacement valve, known as paravalvular regurgitation; and acute kidney injury. Other potential complications include heart attack, infection, valve malposition, allergic reactions and, rarely, emergency surgery or death.

Risk is influenced by pre-existing health conditions, vessel anatomy, valve characteristics and procedural complexity. The team reduces risk through pre-procedure imaging, careful device selection, sterile techniques, medication management and monitoring. Patients should ask which risks are especially relevant to their own situation and what follow-up is planned.

• Potential benefits: relief of valve-related symptoms, improved blood flow and a shorter initial recovery for many patients.
• Important trade-offs: possible pacemaker need, vascular complications, valve leakage and uncertainty about very long-term valve durability for some younger patients.

Recovery timeline and longer-term self-care

Recovery after TAVR varies, but many patients spend a short period in hospital, often one to several days when recovery is uncomplicated. Tiredness, bruising or mild soreness at the access site can occur initially. The clinical team may recommend gradually increasing walking and other light activity while avoiding heavy lifting or strenuous exertion until the access site and overall condition have been reviewed.

Follow-up commonly includes an echocardiogram to assess the new valve, review of blood pressure and heart rhythm, and discussion of medications. Antiplatelet or anticoagulant treatment is individualized; patients should take medicines exactly as directed and report bleeding, black stools, unusual bruising or missed doses. Dental and other procedures may require special advice because preventing infection is important for people with prosthetic heart valves.

Heart-healthy habits remain valuable after valve replacement. These include not smoking, following a balanced eating pattern, remaining physically active as advised, managing blood pressure and diabetes, and attending cardiac rehabilitation when offered. A written TAVR procedure patient education plan can help patients and caregivers organize medicines, appointments and warning signs after discharge.

Should a 78 year old have TAVR or SAVR? When to seek medical care

A 78-year-old may be a candidate for either TAVR or SAVR; age is only one part of the decision. TAVR is often attractive because it avoids opening the chest and may allow a quicker initial recovery, while SAVR may be preferred when anatomy is unsuitable for TAVR, when bypass surgery or other cardiac surgery is needed, or when the surgical team believes it offers the better long-term strategy. The patient’s independence, frailty, life expectancy, valve anatomy and preferences all matter.

Evidence-based care includes a shared decision with the heart team. Patients may find it helpful to ask about the expected benefits, individual complication risks, valve durability, likelihood of needing a pacemaker, recovery expectations and options if the valve needs treatment in the future. A second opinion can also be reasonable when choices are closely balanced.

Medical care should be sought urgently for chest pain, fainting, severe or rapidly worsening breathlessness, new confusion, facial drooping, weakness on one side, speech difficulty or heavy bleeding. After TAVR, urgent review is also needed for fever, chills, increasing redness or drainage at the access site, palpitations with dizziness, or sudden swelling and pain in a leg. Acibadem International’s multidisciplinary specialists at JCI-accredited hospitals assess and treat aortic valve disease for international patients.

Frequently asked questions

What is the success rate of transcatheter aortic valve replacement (TAVR)?

TAVR has high procedural success in experienced centers, meaning the valve can usually be implanted and functions as intended. Outcomes vary according to a person’s age, anatomy, aortic stenosis severity, kidney function, heart function and other illnesses. A heart team can explain the expected benefit and procedural risk using the patient’s own test results.

Is TAVR safer than open-heart valve surgery?

Neither option is universally safer. TAVR is less invasive and may allow a faster early recovery, while surgery may be safer or more durable for some anatomical patterns and for people who need additional cardiac surgery. The safest option is determined through a structured heart-team assessment.

How long does a TAVR valve last?

TAVR valves are designed to be durable, and follow-up evidence continues to grow as more patients are observed over longer periods. Valve durability can differ between individuals and may be particularly important for younger patients with a longer expected lifespan. Regular echocardiograms help clinicians monitor valve function over time.

Will a person need a pacemaker after TAVR?

Some people develop a slow or blocked electrical rhythm after TAVR because the valve sits close to the heart’s conduction system. If the rhythm problem does not resolve or is unsafe, a permanent pacemaker may be recommended. The likelihood depends on the person’s baseline rhythm, anatomy and valve type.

How soon can someone return to normal activity after TAVR?

Many people resume gentle walking and everyday activities relatively soon after an uncomplicated transfemoral TAVR, but recovery is individual. The access site, heart rhythm, energy level and other medical conditions affect timing. The treating team should provide specific guidance about driving, work, exercise and lifting.

Can TAVR be done if someone has coronary artery disease?

Yes, but coronary artery disease requires careful planning. Some patients need coronary artery treatment before, during or after valve replacement, while others can be managed with medication. CT imaging and coronary assessment help the heart team decide on the safest sequence of care.

References

• American College of Cardiology
• American Heart Association
• European Society of Cardiology
• U.S. Food and Drug Administration
• National Heart, Lung, and Blood Institute

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.